No Data
No Data
Rapid Micro Biosystems to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Just Reported And Analysts Have Been Lifting Their Price Targets
Morgan Stanley Maintains Rapid Micro Biosystems(RPID.US) With Hold Rating, Cuts Target Price to $1.5
Morgan Stanley Remains a Hold on Rapid Micro Biosystems (RPID)
Rapid Micro Biosystems Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Market Might Still Lack Some Conviction On Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Even After 32% Share Price Boost
loading...
No Data